Back to Atlas
CTransientStandard research/education caution
CMP-0325
Supplement in some regions
Equol
Phyto-SERM / Nutraceutical
Menopausal, skin, bone, and vascular-health positioning
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Isoflavandiol
- Primary mechanism
- ERβ-preferring phytoestrogen derived from daidzein metabolism
- Primary market use
- Phytoestrogen / menopause
Pharmacology
- Molecular weight (Da)
- 242.27
- Oral bioavailability
- Oral; variable/supplemental
- Half-life
- ~7-10 h
- Route tags
- Topical; oral/other route-dependent
- Evidence level
- Human/supplement research
- Clinical status
- Supplement in some regions
- Value-for-money score
- 6 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Higher potential value than daidzein for equol non-producers if formulated